Efficacy and Safety of Abiraterone Acetate in Elderly (≥75 Years) Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Metastatic castration-resistant prostate cancer primarily affects elderly men. In this post hoc analysis we investigated the safety and efficacy of abiraterone acetate in elderly (≥75 years) and younger (<75 years) patient subgroups at the prespecified interim analysis (55% of total over...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Urol
मुख्य लेखकों: Smith, Matthew R., Rathkopf, Dana E., Mulders, Peter. F.A., Carles, Joan, Van Poppel, Hendrik, Li, Jinhui, Kheoh, Thian, Griffin, Thomas W., Molina, Arturo, Ryan, Charles J.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2015
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129174/
https://ncbi.nlm.nih.gov/pubmed/26151676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2015.07.004
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन